[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

about

[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

Item

http://www.wikidata.org/entity/Q44621004

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

@en

[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

@nl

type

Item

label

[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

@en

[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

@nl

prefLabel

[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

@en

[Platelet function: new drugs, new assays : possible impacts on operative medicine?].

@nl

P1476

[Platelet function: new drugs, new assays : possible impacts on operative medicine?]

@en

P2093

E Mahla

http://www.w3.org/2001/XMLSchema#string

K Huber

http://www.w3.org/2001/XMLSchema#string

M K Freynhofer

http://www.w3.org/2001/XMLSchema#string

T Höchtl

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

Aspirin and mortality from coronary bypass surgery

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation

Prasugrel

P2888

s00101-012-2041-1

P304

483-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00101-012-2041-1

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Florian Prüller

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22695779

http://www.w3.org/2001/XMLSchema#string